Re: Combining 33 genetic variants with prostate-specific antigen for the prediction of prostate cancer: Longitudinal study

European Urology

Volumn 62, Issue 1, 2012, Pages 180-

  Ankerst, Donna P ^a   Thompson, Ian M ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AREA UNDER THE CURVE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LONGITUDINAL STUDY; MALE; NOTE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84861598154     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.04.010     Document Type: Note

References (4)

1. M. Aly, F. Wiklund, and J. Xu Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study Eur Urol 60 2011 21 28
2. S. Lindstroem, F.R. Schumacher, and D. Cox Common genetic variants in prostate cancer risk prediction - results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) Cancer Epidemiol Biomarkers Prev 21 2012 437 444
3. I.M. Thompson, D.P. Ankerst, and C. Chi Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529 534
4. Ankerst DP, Boeck A, Freedland SJ, et al. Evaluating the PCPT Risk Calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. World J Urol. In press.